tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

FDMT Stock Latest News

4D Molecular completes enrollment for 4FRONT-1 Phase 3 trial
The Fly4D Molecular completes enrollment for 4FRONT-1 Phase 3 trial
16h ago
FDMT
4D Molecular assumed with an Overweight at Barclays
PremiumThe Fly
4D Molecular assumed with an Overweight at Barclays
13d ago
FDMT
4D Molecular Therapeutics Restructures Equity via Warrant Exchange
PremiumCompany Announcements
4D Molecular Therapeutics Restructures Equity via Warrant Exchange
14d ago
8K
FDMT
4D Molecular announces employment inducement grants
PremiumThe Fly
4D Molecular announces employment inducement grants
21d ago
FDMT
4D Molecular Therapeutics Expands Leadership With New Director Appointment
PremiumCompany Announcements
4D Molecular Therapeutics Expands Leadership With New Director Appointment
1M ago
8K
FDMT
4D Molecular Therapeutics: Encouraging Early CF Gene Therapy Signals Tempered by Limited Data, Supporting a Neutral Hold Rating
PremiumRatings4D Molecular Therapeutics: Encouraging Early CF Gene Therapy Signals Tempered by Limited Data, Supporting a Neutral Hold Rating
2M ago
FDMT
4D Molecular announces interim data from 4D-710 Phase 1 AEROW trial
Premium
The Fly
4D Molecular announces interim data from 4D-710 Phase 1 AEROW trial
2M ago
FDMT
4D Molecular Therapeutics Expands Phase 3 Trial Enrollment
Premium
Company Announcements
4D Molecular Therapeutics Expands Phase 3 Trial Enrollment
2M ago
8K
FDMT
4D Molecular Therapeutics Appoints New Chief Financial Officer
PremiumCompany Announcements
4D Molecular Therapeutics Appoints New Chief Financial Officer
3M ago
8K
FDMT
4D Molecular names Kristian Humer as CFO
PremiumThe Fly
4D Molecular names Kristian Humer as CFO
3M ago
FDMT
Promising Outlook for 4D Molecular Therapeutics: Buy Rating Backed by Strategic Partnerships and Strong Financial Position
PremiumRatings
Promising Outlook for 4D Molecular Therapeutics: Buy Rating Backed by Strategic Partnerships and Strong Financial Position
3M ago
FDMT
4D Molecular price target raised to $32 from $26 at RBC Capital
PremiumThe Fly
4D Molecular price target raised to $32 from $26 at RBC Capital
3M ago
FDMT
4D Molecular price target lowered to $33 from $38 at Barclays
PremiumThe Fly4D Molecular price target lowered to $33 from $38 at Barclays
3M ago
FDMT
4D Molecular Therapeutics Reports Strategic Gains in Q3 2025
Premium
Company Announcements
4D Molecular Therapeutics Reports Strategic Gains in Q3 2025
3M ago
FDMT
4D Molecular sees cash runway into 2H28
Premium
The Fly
4D Molecular sees cash runway into 2H28
3M ago
FDMT
4D Molecular reports Q3 EPS ($1.01), consensus (98c)
PremiumThe Fly
4D Molecular reports Q3 EPS ($1.01), consensus (98c)
3M ago
FDMT
4D Molecular Therapeutics Closes $93.3 Million Stock Offering
PremiumCompany Announcements
4D Molecular Therapeutics Closes $93.3 Million Stock Offering
3M ago
8K
FDMT
Bullish Outlook on 4D Molecular Therapeutics’ 4D-150: Promising Long-term Efficacy, Safety, and Financial Strength Justify Buy Rating
PremiumRatings
Bullish Outlook on 4D Molecular Therapeutics’ 4D-150: Promising Long-term Efficacy, Safety, and Financial Strength Justify Buy Rating
3M ago
FDMT
4D Molecular upgraded to Equal Weight from Underweight at Morgan Stanley
PremiumThe Fly
4D Molecular upgraded to Equal Weight from Underweight at Morgan Stanley
3M ago
FDMT
4D Molecular’s 4D-150 shows efficacy in Phase 1/2 wet AMD trial
PremiumThe Fly4D Molecular’s 4D-150 shows efficacy in Phase 1/2 wet AMD trial
3M ago
FDMT
4D Molecular 8.386M share Spot Secondary priced at $10.51
Premium
The Fly
4D Molecular 8.386M share Spot Secondary priced at $10.51
3M ago
FDMT
4D Molecular Therapeutics Reports Positive Interim Trial Results
Premium
Company Announcements
4D Molecular Therapeutics Reports Positive Interim Trial Results
3M ago
8K
FDMT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >